Suppr超能文献

伊巴丹的视网膜母细胞瘤:治疗与预后

Retinoblastomas in Ibadan: treatment and prognosis.

作者信息

Ajaiyeoba I A, Akang E E, Campbell O B, Olurin I O, Aghadiuno P U

机构信息

Department of Ophthalmology, University College Hospital, Ibadan, Nigeria.

出版信息

West Afr J Med. 1993 Oct-Dec;12(4):223-7.

PMID:8199065
Abstract

This study reviews the influence of different clinicopathological features of retinoblastoma on outcome and prognosis in 44 Nigerian patients. Twenty-five of the patients had a fatal outcome. These patients were younger and more frequently had bilateral retinoblastomas, orbital tumour recurrence and tumour metastases, compared to patients who had disease free survival. Postoperative tumour recurrence occurred in eleven patients and was commoner in patient who had tumour metastases. Tumour metastases occurred in eighteen of the patients. Though there has been an improvement in the prognosis of retinoblastoma at Ibadan with the advent of radiotherapy, the outlook for children with this neoplasm in this environment is still bleak in comparison with what obtains in developed countries.

摘要

本研究回顾了44例尼日利亚视网膜母细胞瘤患者不同临床病理特征对其结局和预后的影响。其中25例患者预后不良。与无病生存的患者相比,这些患者年龄更小,双侧视网膜母细胞瘤、眼眶肿瘤复发和肿瘤转移更为常见。11例患者术后出现肿瘤复发,且在有肿瘤转移的患者中更为常见。18例患者发生了肿瘤转移。尽管随着放射治疗的出现,伊巴丹视网膜母细胞瘤的预后有所改善,但与发达国家相比,在这种环境下患有这种肿瘤的儿童的前景仍然不容乐观。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验